NUCLIDIUM’s €84M boost positions Europe at forefront of precision cancer therapy

European biotech NUCLIDIUM secured €84M Series B funding to advance copper-based radiopharmaceutical cancer treatments, highlighting Europe’s precision medicine leadership through…

Female-Led Startups in Europe Secure €50M Amid Funding Challenges, Drive Innovation in Biotech and Space Tech

European female-founded startups raised €50M in late April 2025, defying funding headwinds in high-tech sectors like biotech, space logistics, and…